Dizziness and Vertigo _________________________________________________________________________ ANCCTX10DV — 10 CONTACT HOURS R elease D ate : 10/01/24 E xpiration D ate : 09/30/27
Dizziness and Vertigo
Audience This course is designed for physicians and nurses involved in the diagnosis, treatment, and care of patients with dizziness and/or vertigo. Course Objective The purpose of this course is to provide clinicians with the information necessary to appropriately diagnose and treat causes of dizziness and vertigo and improve patients’ quality of life Learning Objectives Upon completion of this course, you should be able to: 1. Identify models used to describe vertigo and dizziness. 2. Outline anatomy and physiology of structures involved in vestibular disorders. 3. List peripheral etiologies of vertigo. 4. Describe the clinical presentations of central etiologies of vertigo. 5. Discuss the causes and underlying pathophysiology of other dizziness/vertigo etiologies (e.g., trauma). 6. Devise a best practice, cost-effective diagnostic workup for patients presenting with dizziness and/or vertigo. 7. Apply diagnostic reasoning and appropriate clinical evaluation and management strategies to the differential diagnosis of dizziness and vertigo. 8. Compare and contrast pharmacotherapy agents that may be used to manage vertigo and dizziness. 9. Analyze the role of vestibular rehabilitation in the clinical management of dizziness/vertigo. 10. Describe other approaches to the management of specific dizziness etiologies. 11. Outline preventive approaches and safety considerations for patients with dizziness/vertigo.
Faculty Mark Rose, BS, MA, LP, is a licensed psychologist in the State of Minnesota with a private consulting practice and a medical research analyst with a biomedical communications firm. Earlier healthcare technology assessment work led to medical device and pharmaceutical sector experience in new product development involving cancer ablative devices and pain therapeutics. Along with substantial experience in addic- tion research, Mr. Rose has contributed to the authorship of numerous papers on CNS, oncology, and other medical disorders. He is the lead author of papers published in peer- reviewed addiction, psychiatry, and pain medicine journals and has written books on prescription opioids and alcoholism published by the Hazelden Foundation. He also serves as an Expert Advisor and Expert Witness to law firms that represent disability claimants or criminal defendants on cases related to chronic pain, psychiatric/substance use disorders, and acute pharmacologic/toxicologic effects. Mr. Rose is on the Board of Directors of the Minneapolis-based International Institute of Anti-Aging Medicine and is a member of several professional organizations. Faculty Disclosure Contributing faculty, Mark Rose, BS, MA, LP, has disclosed no relevant financial relationship with any product manufacturer or service provider mentioned. Division Planners John M. Leonard, MD Mary Franks, MSN, APRN, FNP-C Eli English, PT, DPT Senior Director of Development and Academic Affairs Sarah Campbell Division Planner/Director Disclosure The division planner and director have disclosed no relevant financial relationship with any product manufacturer or service provider mentioned.
Mention of commercial products does not indicate endorsement.
40
EliteLearning.com/Nursing
Book Code: ANCCTX2027
Powered by FlippingBook